Contract Research Organization (CRO)

AKA: Clinical Research Organization.
Context:
- It can provide services such as: Biopharmaceutical Development, Biologic Assay Development, Commercialization, Pre-Clinical Development, Clinical Research, Clinical Trials Management, and Pharmacovigilance.
- It can range from being a Clinical Study CRO, an Observational Study CRO, an Epidemiological CRO, to being a Social Research CRO.
- It can be a member of a ** an Association of Clinical Research Organizations (ACRO).
- …
Example(s):
- OMEGA CRO,
- Medpace,
- Clinispace.
- PPD.
- Cytel, (with ~1,200 employees in 2021).
- IQVIA (with ~64,245 employees in 2021).
- …
Counter-Example(s):
- a Biomedical Therapeutic Research Company.
- a User Study Research Company.
See: Biologic Assay, Pre-Clinical Development, Clinical Research, Clinical Trials, Pharmacovigilance, Medable, Inc..

References

(Wikipedia, 2021) ⇒ https://en.wikipedia.org/wiki/Contract_research_organization Retrieved:2021-4-1.
- A contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, clinical trials management, and pharmacovigilance.
  CROs are designed to reduce costs for companies developing new medicines and drugs in niche markets. They aim to simplify entry into drug markets, and simplify development, as the need for large pharmaceutical companies to do everything ‘in house’ is now redundant. CROs also support foundations, research institutions, and universities, in addition to governmental organizations (such as the NIH, EMA, etc.). ^[1] Many CROs specifically provide clinical-study and clinical-trial support for drugs and/or medical devices. ^[2] CROs range from large, international full-service organizations to small, niche specialty groups. CROs that specialize in clinical-trials services can offer their clients the expertise of moving a new drug or device from its conception to FDA/EMA marketing approval, without the drug sponsor having to maintain a staff for these services. ^[3]

https://linkedin.com/company/medpace/
- QUOTE: ... Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries. ...